Skip to main content

Markets News Screener Research Editorials Pricing About

⌘K

Sign in Start free

Not investment advice. Moatkeep provides data and educational content, not recommendations.

Financial glossary·Pricing·About·Disclaimer·Terms·Privacy·Cookies·Methodology·Support·Company directory·Companies by industry·Feed

© moatkeep 2026

Conexeu Sciences Inc. (CNXU) stock — financials, valuation and filings | Moatkeep

Companies/Nasdaq/CNXU

Conexeu Sciences Inc.

CNXU · Nasdaq

$2.83−1.74%

Close, 2026-10-29Close, 2026-10-29 · source: Databento · USD · figures not investment advice

Data under review

Priceex-date (0) · fiscal quarter (0)

Dividends: company filings (SEC EDGAR) and the historical exchange record.

State of incorporation: NV
Fiscal year end: Oct 31

Valuation snapshot

$141.03M

N/M

19.60

—

-13.25%

—

Close, 2026-09-14

Financials · latest year

Revenue•••••••••••••••

Gross profit•••••••••••••••

Operating income•••••••••••••••

Net income•••••••••••••••

Free cash flow•••••••••••••••

Read the full financial statements

Free accounts read five years of annual financials.

Source: SEC EDGAR (XBRL) · figures in USD millions

Related companies

SAFX — XCF Global, Inc.CDXS — CODEXIS, INC.NRXP — NRX Pharmaceuticals, Inc.GENC — GENCOR INDUSTRIES INC ADAG — Adagene Inc.SATL — Satellogic Inc.HOFT — HOOKER FURNISHINGS Corp OTLK — Outlook Therapeutics, Inc.